2020, Vol. 1, Issue 1, Part A
Bacterial co-infections and secondary infections in COVID-19: An integrative review of the clinical features, pathogens, risk factors and implications on the rational use of antimicrobials
Author(s): Anderson Luiz Pena da Costa, Rafael Lima Resque, Willian Oliveira da Silva and Lennia Alexandra Knupp
Abstract: Co-infections and secondary bacterial infections in COVID-19 are clinical complications associated with high mortality, which require immediate pharmacological treatment with antibiotics, in addition to the prevention and containment measures to prevent the spread of bacterial pathogens among those infected with SARS-CoV-2, mainly in hospitals and intensive care units. However, due to the emerging nature of COVID-19, little is known about co-infections and secondary infections in COVID-19. Therefore, this literature review gathered information on the forms of clinical presentation of bacterial co-infections and secondary infections in COVID-19 bacterial co-infection/secondary infections, as well as laboratory tools that can support clinical decision-making and guide the rational use of antibiotics, since the non-rational use of this pharmacological class has serious consequences for public health concerning the promotion of bacterial resistance.
Pages: 58-66 | Views: 233 | Downloads: 87
Download Full Article: Click Here
How to cite this article:
Anderson Luiz Pena da Costa, Rafael Lima Resque, Willian Oliveira da Silva, Lennia Alexandra Knupp. Bacterial co-infections and secondary infections in COVID-19: An integrative review of the clinical features, pathogens, risk factors and implications on the rational use of antimicrobials. J Adv Microbiol Res 2020;1(1):58-66.
